153 related articles for article (PubMed ID: 27458550)
1. Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia.
Su RJ; Jonas BA; Welborn J; Gregg JP; Chen M
Hum Pathol (N Y); 2016 Sep; 5():6-9. PubMed ID: 27458550
[TBL] [Abstract][Full Text] [Related]
2. Myeloid neoplasm with ETV6::ACSl6 fusion: landscape of molecular and clinical features.
Su Z; Liu X; Hu W; Yang J; Yin X; Hou F; Wang Y; Zhang J
Hematology; 2022 Dec; 27(1):1010-1018. PubMed ID: 36069745
[TBL] [Abstract][Full Text] [Related]
3. t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities.
Baldazzi C; Luatti S; Marzocchi G; Grassi A; Cavo M; Testoni N
Cancer Genet; 2022 Apr; 262-263():35-39. PubMed ID: 34979355
[TBL] [Abstract][Full Text] [Related]
4. Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature.
De Luca-Johnson J; Ninfea JI; Pearson L; Conant J; Bryant R; Zakai NA; Tang ME
Case Rep Med; 2016; 2016():8324791. PubMed ID: 27746819
[TBL] [Abstract][Full Text] [Related]
5. A Novel
Zhao C; Wang M; Zhan Y; Xu Y; Chen S; Wang Q; An J; Liu T
Front Oncol; 2022; 12():887945. PubMed ID: 35747804
[TBL] [Abstract][Full Text] [Related]
6. Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13).
Yagasaki F; Jinnai I; Yoshida S; Yokoyama Y; Matsuda A; Kusumoto S; Kobayashi H; Terasaki H; Ohyashiki K; Asou N; Murohashi I; Bessho M; Hirashima K
Genes Chromosomes Cancer; 1999 Nov; 26(3):192-202. PubMed ID: 10502316
[TBL] [Abstract][Full Text] [Related]
7. ETV6-ACSL6 fusion gene in myeloid neoplasms: clinical spectrum, current practice, and outcomes.
Wu X; Cai H; Qiu Y; Li J; Zhou DB; Cao XX
Orphanet J Rare Dis; 2020 Jul; 15(1):192. PubMed ID: 32723365
[TBL] [Abstract][Full Text] [Related]
8. T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
Schoelinck J; Gervasoni J; Guillermin Y; Beillard E; Pissaloux D; Chassagne-Clement C
Virchows Arch; 2024 May; 484(5):853-857. PubMed ID: 37985498
[TBL] [Abstract][Full Text] [Related]
9. Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
Zhang Y; Nguyen L; Lu CM; Wang E; Lauw MIS; Ball S; Dong N; Moscinski L; Chan O; Yun S; Sallman D; Sokol L; Shah B; Knepper T; Lancet J; Komrokji R; Padron E; Kuykendall A; Zhang L
Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):e150-e163. PubMed ID: 36624015
[TBL] [Abstract][Full Text] [Related]
10. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
[TBL] [Abstract][Full Text] [Related]
11. Updates on eosinophilic disorders.
Tzankov A; Reichard KK; Hasserjian RP; Arber DA; Orazi A; Wang SA
Virchows Arch; 2023 Jan; 482(1):85-97. PubMed ID: 36068374
[TBL] [Abstract][Full Text] [Related]
12.
Xu W; Tian F; Tai X; Song G; Liu Y; Fan L; Weng X; Yang E; Wang M; Bornhäuser M; Zhang C; Lock RB; Wong JWH; Wang J; Jing D; Mi JQ
Haematologica; 2024 Feb; ():. PubMed ID: 38356460
[TBL] [Abstract][Full Text] [Related]
13. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.
Chung A; Hou Y; Ohgami RS; Von Gehr A; Fisk DG; Roskin KM; Li X; Gojenola L; Bangs CD; Arber DA; Fire AZ; Cherry AM; Zehnder JL; Gotlib J; Merker JD
Cancer Genet; 2017 Oct; 216-217():10-15. PubMed ID: 29025582
[TBL] [Abstract][Full Text] [Related]
14. t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity.
Mueller SB; Dal Cin P; Le LP; Dias-Santagata D; Lennerz JK; Iafrate AJ; Marble HD; Brunner AM; Weinstock MJ; Luskin MR; De Angelo DJ; Stone RM; Nardi V
Blood Adv; 2022 Jan; 6(3):818-827. PubMed ID: 34587239
[TBL] [Abstract][Full Text] [Related]
15. A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia.
Oberley MJ; Denton C; Ji J; Hiemenz M; Bhojwani D; Ostrow D; Wu S; Gaynon P; Raca G
Cancer Genet; 2017 Oct; 216-217():91-99. PubMed ID: 29025601
[TBL] [Abstract][Full Text] [Related]
16. Myeloid/Lymphoid Neoplasms with
Gou Y; Tang Y; Liu S; Cheng S; Deng X; Wen Q; Feng Y; Peng X; Wang P; Zhang X
J Inflamm Res; 2023; 16():5163-5170. PubMed ID: 38026242
[TBL] [Abstract][Full Text] [Related]
17. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
18. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
[TBL] [Abstract][Full Text] [Related]
19. Long-chain acyl-CoA synthetase 6 regulates lipid synthesis and mitochondrial oxidative capacity in human and rat skeletal muscle.
Teodoro BG; Sampaio IH; Bomfim LH; Queiroz AL; Silveira LR; Souza AO; Fernandes AM; Eberlin MN; Huang TY; Zheng D; Neufer PD; Cortright RN; Alberici LC
J Physiol; 2017 Feb; 595(3):677-693. PubMed ID: 27647415
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]